Sort
326,823 grants matching “clinical trial”
AAA Disease: Mechanism, Stratification and Treatment
$2,373,422Ronald L Dalman · Stanford University · P50 · FY2008 · HL
Frontotemporal Dementia: Genes, Images, and Emotions
$2,373,110Bruce L Miller · University Of California, San Francisco · P01 · FY2018 · AG
The Tisch Cancer Institute - Cancer Center Support Grant
$2,373,000Ramon E Parsons · Icahn School Of Medicine At Mount Sinai · P30 · FY2018 · CA
The Tisch Cancer Institute - Cancer Center Support Grant
$2,373,000Steven J. Burakoff · Icahn School Of Medicine At Mount Sinai · P30 · FY2016 · CA
The Tisch Cancer Institute - Cancer Center Support Grant
$2,373,000Ramon E Parsons · Icahn School Of Medicine At Mount Sinai · P30 · FY2017 · CA
Clinical Trials Monitoring Service
$2,373,000Theradex Systems, Inc. · N02 · FY2008 · CA
The Tisch Cancer Institute - Cancer Center Support Grant
$2,373,000Ramon E Parsons · Icahn School Of Medicine At Mount Sinai · P30 · FY2019 · CA
DEVELOPMENT/TESTING OF ARTIFICIAL RETINAS FOR THE BLIND
$2,372,959Second Sight Medical Products, Inc. · R24 · FY2004 · EY
BIOLOGICAL MARKERS OF BREAST CANCER &TAMOXIFEN RESPONSE
$2,372,848University Of Pennsylvania · P01 · FY2001 · CA
PREVENTABLE Trial Implementation Phase
$2,372,685Karen P Alexander · Duke University · U19 · FY2022 · AG
Leveraging Observational (Real World) Data to Advance Precision Oncology
$2,372,456Charles L Sawyers · Sloan-Kettering Inst Can Research · P01 · FY2024 · CA
Frontotemporal Dementia: Genes, Images, and Emotions
$2,372,303Bruce L Miller · University Of California, San Francisco · P01 · FY2020 · AG
Anti-Viral therapy in Alzheimer's disease
$2,372,211Davangere P Devanand · Columbia University Health Sciences · R01 · FY2020 · AG
Anti-Viral therapy in Alzheimer's disease
$2,372,211Davangere P Devanand · Columbia University Health Sciences · R01 · FY2019 · AG
Cancer Research Consortium of West Michigan (CRCWM)
$2,372,116Kathleen J Yost · Corewell Health · UG1 · FY2019 · CA
Central Hub for Kidney Precision Medicine - Administrative Core
$2,371,992Jonathan Himmelfarb · University Of Washington · U2C · FY2019 · DK
Integrated Care for Chronic Pain and Opioid Use Disorder: The IMPOWR Research Center at Montefiore/Einstein (IMPOWR-ME)
$2,371,942Joanna L. Starrels · Albert Einstein College Of Medicine · RM1 · FY2024 · DA
Cochlear Synaptopathy: Prevalence, Diagnosis and Functional Consequences
$2,371,694Sharon Kujawa · Massachusetts Eye And Ear Infirmary · P50 · FY2019 · DC
Cochlear Synaptopathy: Prevalence, Diagnosis and Functional Consequences
$2,371,694Sharon Kujawa · Massachusetts Eye And Ear Infirmary · P50 · FY2020 · DC
Validating remote digital assessments for familial frontotemporal dementia
$2,371,437Adam Mark Staffaroni · University Of California, San Francisco · RF1 · FY2022 · AG
COVID-19 Clinical Support and Research
$2,371,299Adrian McDermott · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Causes and Consequences of Healthcare Efficiency
$2,371,285Amber E Barnato · Dartmouth College · P01 · FY2022 · AG
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH
$2,371,140Robert Stanley Sherwin · Yale University · UL1 · FY2011 · RR
Model-based predictions of responses RTK Pathway therapies
$2,370,950Joe W. Gray · Oregon Health & Science University · U54 · FY2012 · CA
Cancer Center Support Grant
$2,370,872Ruben A Mesa · Wake Forest University Health Sciences · P30 · FY2022 · CA